# Preventive Effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal Jaundice

> **NCT06087874** · PHASE2 · RECRUITING · sponsor: **Chinese University of Hong Kong** · enrollment: 94 (estimated)

## Conditions studied

- Neonatal Jaundice
- Microtia
- Pregnancy Related
- Hyperbilirubinemia, Neonatal

## Interventions

- **DIETARY_SUPPLEMENT:** Vivomixx®
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT06087874
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-23
- **Primary completion:** 2025-02
- **Final completion:** 2025-06
- **Target enrollment:** 94 (ESTIMATED)
- **Last updated:** 2024-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06087874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06087874, "Preventive Effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal Jaundice". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06087874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*